Publication: Multiple sclerosis: association with the interleukin-1 gene family polymorphisms in the Turkish population
| dc.contributor.author | ARMAN, AHMET | |
| dc.contributor.author | ÇOKER GÜRKAN, AJDA | |
| dc.contributor.authors | Isik, Nihal; Arman, Ahmet; Canturk, Ilknur Aydin; Gurkan, Ajda Coker; Candan, Fatma; Aktan, Sule; Erzaim, Nilufer; Duz, Ozge Arici; Aydin, Tugrul; Turkes, Muzaffer; List, Edward O. | |
| dc.date.accessioned | 2022-03-12T18:11:06Z | |
| dc.date.accessioned | 2026-01-11T19:12:13Z | |
| dc.date.available | 2022-03-12T18:11:06Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Background: Multiple Sclerosis (MS) is a neurodegenerative disease. It involves inflammation and demyelination. Since cytokines play an important role in the development of MS, genes encoding cytokines such as the Interleukin (IL)-1 family are candidate genes for MS susceptibility. Objective: To determine the relationship between IL-1 gene family and MS in the Turkish population. Methods: A total of 409 MS patients and 256 healthy controls were included in the study. IL-1A -889 (rs1800587), IL-1 RN variable number tandom repeat (VNTR), IL-1B -511 (rs 16944) and IL-1B +3953 (rs 1143634) polymorphisms were investigated from the genomic DNA, obtained via blood samples. Results: No association was found between IL-1A and IL-1RN polymorphisms and susceptibility to MS. However, we have found significantly decreased frequency of IL-1B -511 genotype (p = 0.004) in MS patients compared to controls. In addition, there was a significant association between IL-1B -511 (1/2) genotype and early onset MS (EOMS) (p = 0.0001). Conclusions: Individuals with the 2/2 genotype of IL-1B -511 have significantly decreased incidence of MS, suggesting a protective role for this genotype in the Turkish population. Additionally, IL-1B -511(1/2) genotype was determined as a possible risk factor for EOMS. | |
| dc.identifier.doi | 10.3109/00207454.2013.795563 | |
| dc.identifier.eissn | 1563-5279 | |
| dc.identifier.issn | 0020-7454 | |
| dc.identifier.pubmed | 23594042 | |
| dc.identifier.uri | https://hdl.handle.net/11424/231428 | |
| dc.identifier.wos | WOS:000324449000006 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | INTERNATIONAL JOURNAL OF NEUROSCIENCE | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | demyelinating disease | |
| dc.subject | interleukin-1 | |
| dc.subject | cytokine | |
| dc.subject | genotype distribution | |
| dc.subject | RECEPTOR ANTAGONIST IL-1RA | |
| dc.subject | DISEASE SEVERITY | |
| dc.subject | RHEUMATOID-ARTHRITIS | |
| dc.subject | ADHESION MOLECULE | |
| dc.subject | IL-1-BETA | |
| dc.subject | SUSCEPTIBILITY | |
| dc.subject | CELLS | |
| dc.subject | RISK | |
| dc.subject | RELEVANCE | |
| dc.subject | INTRON-2 | |
| dc.title | Multiple sclerosis: association with the interleukin-1 gene family polymorphisms in the Turkish population | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 718 | |
| oaire.citation.issue | 10 | |
| oaire.citation.startPage | 711 | |
| oaire.citation.title | INTERNATIONAL JOURNAL OF NEUROSCIENCE | |
| oaire.citation.volume | 123 |
